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Sex differences in DNA methylation 
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Veronica Luiza Vale Euclydes2, Alexandra Brentani3, Günther Fink4, Angelica de Baumont2, 
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Guilherme Vanoni Polanczyk2, Euripedes Constantino Miguel2 & Helena Brentani2
Sex differences in the prevalence of psychiatric disorders are well documented, with exposure to 
stress during gestation differentially impacting females and males. We explored sex-specific DNA 
methylation in the cord blood of 39 females and 32 males born at term and with appropriate weight 
at birth regarding their potential connection to psychiatric outcomes. Mothers were interviewed to 
gather information about environmental factors (gestational exposure) that could interfere with 
the methylation profiles in the newborns. Bisulphite converted DNA was hybridized to Illumina 
HumanMethylation450 BeadChips. Excluding XYS probes, there were 2,332 differentially methylated 
CpG sites (DMSs) between sexes, which were enriched within brain modules of co-methylated CpGs 
during brain development and also differentially methylated in the brains of boys and girls. Genes 
associated with the DMSs were enriched for neurodevelopmental disorders, particularly for CpG sites 
found differentially methylated in brain tissue between patients with schizophrenia and controls. 
Moreover, the DMS had an overlap of 890 (38%) CpG sites with a cohort submitted to toxic exposition 
during gestation. This study supports the evidences that sex differences in DNA methylation of 
autosomes act as a primary driver of sex differences that are found in psychiatric outcomes.
Epigenetics is a dynamic biological mechanism involved in the modulation of an individual’s genome to envi-
ronmental stimuli. Much of the epigenome is established during embryogenesis and early gestation and is trans-
mitted in a relatively stable fashion1. Among the epigenetic factors, DNA methylation is thought to contribute 
to stable long-term regulation of gene expression. A large study in families with twins reported methylation 
differences dependent on genetic factors and environment2. Due to the stability, DNA methylation might be 
related to the development of psychiatric diseases later in life3. Several studies pointed out to a correspondence at 
methylation levels between blood and brain within individuals, suggesting that, although with some restrictions, 
blood can be used as a source to study psychiatric diseases4,5.
During perinatal sensitive periods, the environment exerts a critical impact on the maturation of brain struc-
ture and function6–10. It has been well characterized in humans that exposure to external damaging agents, such as 
smoking, mercury and arsenic during gestation induced epigenetic alterations in newborns11–13. Likewise, early life 
adversity, including pre- and post-natal stress, increased the risk of psycopathologies in animal models14. In humans, 
the Dutch Hunger Winter studies demonstrated the relationship between famine exposure at different times of 
prenatal development and phenotypic outcomes. Famine exposure around the period of conception was associated 
with increased risk of adult schizophrenia15, and with persistent changes in DNA methylation for INSIGF, GNASAS, 
LEP, MEG3, IL10 and ABCA116. Furthermore, epidemiological studies indicated that psychological stress such as 
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bereavement, unwanted pregnancies, military invasion and natural disasters increased the risk for the offspring to 
develop neurodevelopmental diseases later in life, such as schizophrenia, depression and anxiety17–20.
The relation between psychiatric diseases and adverse experience in early life were included in the 
Developmental Origins of Health and Disease (DOHaD) hypothesis. Most DOHaD diseases have a sex-biased 
susceptibility21,22, suggesting that the response to stress is different in males and females. Accordingly, when 
exposed to stress, males suffer from behavioral problems earlier in development - at one year of age23, whilst 
females show the effects at later life periods24,25. In addition, there is a clear temporal specificity and sexually 
dichotomous influence of the effects of prenatal stress26–28. Males seem to be more vulnerable to develop schizo-
phrenic, autism and attention-deficit/hyperactivity disorder (ADHD) symptoms in response to perinatal stress, 
all these were associated with intra uterus growth restriction (IUGR)29,30.
Animal models also contributed to association between methylation alterations and different response to 
stress exposition in females and males. For instance, intrauterine exposure to Bisphenol A (BPA), an estrogenic 
endocrine disruptor, seems to induce DNA methylation changes in male cortex and in female hypothalamus 
as result of expression changes in ESR1 and DNMT131. In mice, treatment with valproic acid during gestation 
induced sex-specific morphological alterations at a discreet region of the midbrain, including a higher cell 
counts in males compared to females14. In mice, exposure to stress in the prenatal period caused elevation of 
DNMT1 expression levels in females’ placenta, but not males. Contrariwise, males showed response to mala-
daptive behavioral stress together with change in methylation and expression of the glucocorticoid receptor and 
corticotropin-releasing factor in the fetal brain28.
A correlation between changes in methylation and gene expression were suggested to be involved with the 
differential brain development32. Thus, differences in the regulation of gene expression between females and 
males could explain the variances in specific brain structure8,27,28,32,33, cognitive abilities and stress-coping strate-
gies28 Some studies already evaluated sex differences at methylation levels between females and males in the cord 
blood34, prefrontal cortex32,35 and pancreatic isolates35, nevertheless, none considered exposition to stress. Whilst 
it is known that the developing brain has enhanced sex-biased sensitivity to environmental stimuli at specific 
periods of gestation that contributes to vulnerability to psychiatric diseases, the possibility that DNA methylation 
differences between females and males could be involved with psychiatric diseases, independently of exposition 
to stress, remains to be addressed.
To unveil the contribution of stress exposition and the sexual antagonism effects in DNA methylation as 
well as their association with psychiatric vulnerabilities, we conducted a genome-wide methylation analy-
sis of cord-blood in a well-characterized cohort of children born at term and of adequate weight/size at birth. 
Adjustments for cell heterogeneity and stress exposure co-variables were performed followed by the identification 
of differentially methylated CpG sites (DMSs) between females and males. These methylation differences were 
explored in other cohorts, including brain development, neurodevelopmental disorders and a cohort where chil-
dren were exposed to stress during gestation.
Results
General characteristics of the study population. We used a natural cohort of newborns collected at the 
University Hospital of São Paulo Medical School, where, typically, only mothers with a not at risk pregnancy do 
have labor. We randomly collected cord blood samples from 96 individuals. Then, we excluded six pre-term and 
two post-term newborns, as well as 11 small and seven large for gestational age newborns, since those presenta-
tions have already been associated with psychiatric outcomes and stress exposition36. The final cohort included 
71 cases, comprised of 39 females and 32 males, all with adequate weigh/size for gestational age and born at term. 
Moreover, to maximize differences in methylation probably related to sexes differences, we corrected for other 
exposure variables that could interfere with the analysis (Table 1, Supplemental Table 1) explored by this study 
(females versus males). Although smoking were different between females and males (p = 0.034), only psychiatric 
disease in father’s family presented a significant value as given by the sva package analysis (Supplemental Figure 1) 
and was corrected accordingly. In addition, data were adjusted for batch effects and cell type composition. Only as 
a proof of concept, the sex of each sample was confirmed by methylation levels of sexual chromosomes. The study 
design was included as a chart showing the analyses flow (Supplemental Figure 2).
Methylation differences between sexes correlate with gene expression. To characterize methylation 
changes in the cord blood of females and males, methylation levels were derived for 464,964 CpG sites, excluding 
XYS probes. Supervised comparison between sexes identified 2,332 differentially methylated CpG sites (DMSs) 
with females presenting twice the number of hypermethylated sites compared to males (adjP < 0.05, 1,546 and 
786 CpG sites more methylated in females and males, respectively), with 1,499 CpG sites associated to 1,113 genes 
(Fig. 1; Supplemental Table S2). Upon clustering of the 2,332 CpG sites (Euclidian distance with average linkage), 
two clusters formed, completely separating both sexes (Supplemental Figure 3).
To evaluate if DMSs were associated with differentially expressed genes between females and males, we used 
an expression dataset of 2,500 samples from 13 tissues37. Excluding genes located in the sexual chromosomes, the 
1,113 genes were enrichment among differentially expressed genes between females and males in five tissues, four 
being brain regions (anterior cingulate cortex, frontal cortex, cerebellum and hippocampus), and the fifth being 
heart (Supplemental Table 3).
Considering that the 1,113 genes have a sex-biased expression, we used MiSig/WebGestalt to verify 
if there was an enrichment of binding sites for estrogen and androgen receptors and binding sites located at 
2 Kb up or downstream from transcriptional start site (TSS) of each of gene. This analysis resulted in 105 genes 
regulated by estrogen receptor alpha or beta (five motifs, adjP < 0.05), 24 genes regulated by androgen receptor 
(three motifs, adjP < 0.05), and ten genes regulated by both transcriptional factors. Then, to explore more 
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distant motifs, we used Opossum38 that searched for transcriptional factors target sites located at 5 Kb or 10 Kb 
up or downstream from TSS of 838 (out of 1,113) genes, revealing no enrichment for ESR1 or AR binding sites 
(Supplemental Table 4).
Differentially methylated CpG sites are not randomly distributed within the genome. Females 
have twice the number of methylated CpGs sites than males, with a non-random distribution in the genome. CpG 
sites more frequently methylated in females were more often located near transcriptional start sites (TSS1500) 
and within CpG islands, S_shores and S_shelves. Conversely, CpG sites more frequently methylated in males were 
enriched within gene bodies and 3′ UTR, and were associated with open sea areas (Supplemental Table 5, chi-square 
test, p < 0.05). Based on the predefined regions, the differentially methylated regions (DMRs) between females 
and males were distributed as follow: 171 CpG islands (98 and 73 hyper- and hypomethylated in females), 131 
promoters (80 and 51 hyper- and hypomethylated in females), 127 genes (64 and 63 hyper- and hypomethylated 
in females) and 333 genome-wide tiling regions (169 and 164 hyper- and hypomethylated in females) 
(Supplemental Figure 4, Supplemental Table 6, adjP < 0.05). The top DMRs (adjP < 0.05 and at least 10 CpG sites) 
are shown in Table 2.
Male (n = 32) Female (n = 39)
P valuen % Mean (±SD) n % Mean (±SD)
Mothers
-Age (years) 26.9 (5.9) 29.4 (7.0) 0.133
≤ 18 0 1 2.56
19–35 29 90,7 31 79.5
≥ 36 3 9.3 7 17.9
-Educational level 0.840
Unlettered 2 6.5 1 2.6
Elementary school 11 35.5 14 35.9
High school 17 54.8 20 51.3
College 0 1 2.6
Unknown 1 3.2 3 7.7
Income (Minimal wages) 4.0 (1.0) 4.5 (0.8) 0.399
≤ 2 9 29.0 18 46.1
3–4 11 35.5 14 35.9
≥ 5 7 22.6 3 7.7
Unknown 4 12.9 4 10.3
-Type of delivery 0.815
Normal 17 57.7 21 53.9
Cesarean section 13 43.3 18 46.1
-Planned gestation 26 83.9 34 87.2 0.727
-Self-reported environmental factors
-Stress during gestation 15 48.4 20 51.3 0.525
-Feelings during gestation 0.546
Most time, positive 18 58.1 18 46.2
Soft stress 4 12.9 10 25.6
Moderate stress 6 19.4 5 12.8
Abortion was considered 2 6.5 5 12.8
Severe stress 1 3.1 1 2.6
-Psyquiatric drugs during 
pregnancy 0 2 5.1 0.201
-Smoking during gestation 2 6.3 10 25.6 0.034
-Drugs/alcool during pregnancy 12 38.7 9 23.1 0.156
Neonates
-Gestational age (weeks) 30 39.5 (1.4) 39 39.4 (1.2) 0.876
-Birth Weight (g) 30 3359.2 (396) 39 3298.2 (321) 0.482
-Length 30 49.3 (1.7) 39 48.1 (1.8) 0.009
-Cephalic circumference 30 34.7 (1.3) 38 34.2 (1.0) 0.123
-Thoracic circumference 30 33.2 (1.4) 38 33.2 (1.4) 0.963
-Abdominal circumference 30 31.9 (1.6) 38 32.3 (1.8) 0.361
Table 1.  Characteristics of the cohort and factors evaluated as covariables of the analyses.
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Differentiated methylated sites between males and females are related to genes associated 
with normal brain development and neurodevelopment disorders. To gather a global view of the 
role of these genes, the 1,113 genes were annotated into gene ontology, revealing over-representation of genes 
related to system development, neurogenesis and neuron differentiation, striated muscle cell differentiation, and 
single organism behavioral and synaptic transmission. In addition, we found enrichment of genes belonging to 
the metabolic pathway (60 genes), the MAPK signaling pathway (23 genes), and focal adhesion (19 genes), among 
others (adjP < 0.01), including the insulin signaling pathway (12 genes). Finally, we observed an enrichment of 
genes related to neuropsychiatric disorders, stress, cancer, congenital disorders, musculoskeletal including cardi-
ovascular diseases, endocrinological and female and male genitourinary diseases (Supplemental Table 7).
To test if the 1,113 genes were associated with brain development, we searched in the Allen Brain Atlas and 
found that 930 genes were expressed in at least one of the 26 brain regions (8th post-conception week to 40 
years of age). Next, the comparison between the 2,332 DMS and the 7% of CpGs that changes the methylation 
during brain development39 showed an enrichment, represented by 238 CpGs (p <  0.00001, 
Supplemental Figure 5). Further, we compared to the 521 CpG sites that, in addition to being modulated during 
brain development, were also differentially methylated between brains of females and males, resulting in 195 
common CpG sites (p < 0.00001, Supplemental Figure 5). Finally, extracting data from the only study in schizophrenia 
that had used the 450 K Beadchip arrays with publicly available data40 we searched for enrichment between 
2,332 DMS between females and males and the 4,641 differentially methylated CpG sites in brain tissue from 
schizophrenic cases and controls. The analysis reported an overlap of 116 CpG sites between both studies, indicating 
an enrichment for CpG sites related to schizophrenia among CpG sites that differ between females and males in 
cord blood (p = 0.0139, Supplemental Figure 5).
Differentiated methylated sites between females and males are enriched for psychiatric dis-
orders in a stress exposition model. To further explore the enrichment of DMSs between sexes after 
correction for stress exposition among genes associated with psychiatric disorders, we compared our DMSs to 
the differentially methylated CpG sites in the cord blood between females and males exposed to stress (toxic 
agents) during gestation from an independent cohort. A study from CHAMACOS (a longitudinal birth cohort 
study of the effects of exposure to pesticides and environmental chemicals on the health and development of 
Mexican-American children living in the agricultural region of Salinas Valley, CA) assessed the methylation 
changes related to sex differences in the cord blood of females and males, taking into account batch effects and cell 
composition. Excluding XYS CpG sites, they found 3,031 DMS (25.7% of the total) located in the autosomes, with 
most of them (82%) more methylated in females34. We compared these to our 2,332 DMS and found 890 (38%) 
common DMSs, all presenting the same pattern regarding hypo- and hypermethylation.
To assess whether there was an enrichment of genes associated with psychiatric diseases in both data sets, 
CHAMACOS‘ and ours, we used only those DMSs related to genes. Considering that one gene may have more 
than one CpG site, and different CpG sites may have opposing methylation differences (hypo- or hypermeth-
ylated), depending on their location, we excluded genes represented by more than one CpG site. This analy-
sis resulted in 472 common genes between CHAMACOS‘ and ours, 1,309 and 500 genes belonging exclusively 
to CHAMACOS‘ or our datasets, respectively. Next, an enrichment analysis for diseases were performed with 
full datasets followed by the enrichment analysis with common and exclusive genes of the two cohorts that 
showed that, considering all diseases, most of the psychiatric diseases were enriched in all datasets, although 
there were differences in the ranking as exemplified by the top ten diseases (Supplemental Table 8, diseases and 
schizophrenia).
These gene sets were tested for enrichment in modules of co-expressed genes along human neocortical 
development41 (Supplemental Table 9). M8, M13 and M17 were enriched within the full datasets and among 
common genes. M8 is comprised of genes more expressed in the beginning of gestation; genes from M13 present 
a decreasing expression until postconception week (PCW) 16, from which point present an increasing pattern; 
Figure 1. Characterization of the differentially methylated CpG sites between females and males. Volcano 
plot of the differential methylation analysis with X and Y axes displaying, respectively, the delta-beta values and 
the log10 of adjusted p-values for each CpG site. CpGs more methylated in females and males are represented in 
pink and blue, respectively.
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ID Chromosome Start End Gene symbol entrezID Mean difference Combined adjP CpG sites
CpG islands
20510 chr17 20798958 20800112 − 0,046 3,79E-03 11
22902 chr19 6495193 6496225 − 0,017 1,94E-03 10
25607 chr21 27106815 27108211 − 0,003 2,13E-03 10
4617 chr3 57993839 57994704 0,007 1,11E-02 12
3768 chr2 208576002 208577106 0,016 1,68E-03 10
4494 chr3 49394856 49395942 0,017 1,08E-02 10
18564 chr15 101094521 101099493 0,020 7,65E-03 13
18889 chr16 2569560 2571071 0,024 1,22E-02 13
16491 chr13 25874995 25876200 0,026 3,76E-02 12
7248 chr5 149546028 149546988 0,058 2,20E-03 10
Promoters
ENSG00000237268 chr7 56515569 56517568 NA NA − 0,047 9,62E-03 13
ENSG00000205212 chr17 20798954 20800953 CCDC144NL 339184 − 0,042 1,02E-02 12
ENSG00000155918 chr6 150346169 150348168 RAET1L 154064 − 0,020 3,75E-02 11
ENSG00000136068 chr3 57992627 57994626 FLNB 2317 0,007 1,39E-02 12
ENSG00000163249 chr2 208574764 208576763 CCNYL1 151195 0,017 1,91E-03 10
ENSG00000162066 chr16 2568858 2570857 AMDHD2 51005; 752014 0,026 1,21E-02 13
ENSG00000139496 chr13 25874162 25876161 NUPL1 9818 0,027 4,45E-02 13
ENSG00000157911 chr1 2344737 2346736 PEX10 5192 0,040 8,61E-03 13
ENSG00000113722 chr5 149544858 149546857 CDX1 1044 0,046 4,24E-02 10
Genes
ENSG00000189136 chr15 85070012 85114447 UBE2Q2P1 388165 − 0,022 9,38E-05 10
ENSG00000120705 chr5 137841784 137878989 ETF1 2107 − 0,009 1,24E-02 10
ENSG00000164754 chr8 117858174 117887105 RAD21 5885 − 0,008 3,62E-02 12
ENSG00000100902 chr14 35747839 35786699 PSMA6 5687 − 0,004 2,32E-02 12
ENSG00000154727 chr21 27106881 27144771 GABPA 2551 − 0,003 4,83E-02 15
ENSG00000154723 chr21 27088815 27107984 ATP5J 522 − 0,001 3,91E-02 14
ENSG00000176714 chr2 27848506 27851879 CCDC121 79635 0,016 6,56E-05 12
ENSG00000241186 chr3 46616045 46668033 TDGF1 6997 0,016 7,33E-03 18
ENSG00000196781 chr9 84198598 84304220 TLE1 7088 0,030 5,00E-05 16
ENSG00000110243 chr11 116660083 116663136 APOA5 116519 0,034 1,68E-02 10
ENSG00000163749 chr4 77234154 77343021 CCDC158 339965 0,034 3,55E-02 12
ENSG00000175773 chr11 130184888 130263688 NA NA 0,039 7,27E-05 14
ENSG00000121410 chr19 58856544 58864865 A1BG 1 0,050 1,42E-02 12
ENSG00000268895 chr19 58859117 58866549 A1BG-AS1 503538 0,054 2,79E-03 12
Genome-wide tiling regions
258039 chr7 56515001 56520000 − 0,046 2,44E-02 15
278217 chr7 157405001 157410000 − 0,044 4,02E-02 14
504201 chr17 20795001 20800000 − 0,039 2,28E-02 13
478486 chr15 85110001 85115000 − 0,020 6,65E-04 11
533197 chr19 6495001 6500000 − 0,014 1,94E-02 12
41882 chr1 209405001 209410000 − 0,010 1,88E-02 10
447146 chr14 35760001 35765000 − 0,005 4,10E-02 10
55422 chr2 27850001 27855000 0,011 2,56E-02 20
91567 chr2 208575001 208580000 0,014 1,66E-02 12
481683 chr15 101095001 101100000 0,021 2,99E-03 11
340633 chr10 22765001 22770000 0,024 1,52E-02 11
96502 chr2 233250001 233255000 0,027 4,67E-02 11
107815 chr3 46615001 46620000 0,032 5,47E-03 10
137680 chr3 195940001 195945000 0,033 2,59E-02 13
507646 chr17 38020001 38025000 0,038 2,43E-03 11
213529 chr6 5085001 5090000 0,039 4,10E-02 14
206237 chr5 149545001 149550000 0,045 2,93E-02 13
549738 chr20 30070001 30075000 0,047 3,07E-02 12
66673 chr2 84105001 84110000 0,050 2,35E-08 11
543670 chr19 58860001 58865000 0,065 7,02E-04 10
Table 2.  Differentially methylated regions in predefined genomic regions with adjusted p-value < 0.05 and 
containing at least 10 CpG sites.
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and genes from M17 increase after PCW 16 until birth, from which point it seems to reach a plateau. Genes 
exclusively from this study (n = 500) were enriched for M9 (p = 0.0009), which contains genes highly expressed 
in the beginning of gestation that decrease expression levels at around 12th week whereas genes exclusively from 
CHAMACOS‘ (n = 1,309) were enriched for M15 (p = 0.0246), that presents an increasing level of expression 
during the whole neocortical development. Genes found only by CHAMACOS study (total or exclusive genes) 
were enriched for M1, that present a decreasing expression until week 12th, from which point present a constant 
increasing expression levels (Fig. 2).
Discussion
Differences underlying sexes have been associated with distinct incidence and severity of a group of psychiatry 
diseases, although the mechanisms are not well understood, moreover, differential methylation has been involved 
with this sex bias prevalence of psychiatry disorders. The immune system response during certain periods of 
development has sex-specific effects on regulation of various neurotransmitters important for the stress response 
throughout life, with consequences for physical and psychiatric disorders in later life36. Besides, there is a clear sex 
dimorphism in structures during brain development that were implicated to a sex-bias vulnerability to psychiatric 
disorders independent of stress exposition42. The potential underlying mechanisms driving these sex differences 
regarding stress responses and their relevance to disease were deeply discussed. The authors concluded that the 
continued focus and appreciation for how sex differences in stress responses may predict disease risk and resil-
iency is critical for developing preventive strategies and treatments43. In this study, we conducted a genome-wide 
DNA methylation profile of cord blood of a well-characterized cohort composed of babies born at term and 
with adequate weight, after correcting for stress exposition factors that could interfere with DNA methylation. 
We showed that differential methylation between females and males found in the cord blood can represent gene 
expression differences in tissues with sex dimorphism.
The DMS were equally distributed across all 22 autosomes, as previously described34, but their locations were 
not random. Whilst females had more methylated CpGs associated with repressed gene expression, males had 
more methylated CpGs in the open sea, which is more often positively correlated with expression44,45.
Pathways enriched for the 1,113 genes related to the DMS between sexes included metabolic and MAPK 
pathways. Changes in the metabolism of 1-carbon and methyl donor availability in the fetal liver, a major meta-
bolic organ, were suggested to have a sex influence in a subset of genes46. Several pathways related to muscle were 
over-represented, such as the hypertrophic cardiomyopathy and vascular smooth muscle contraction pathways. 
The development and establishment of musculature is thought to be a major difference between adult males and 
females. At molecular level, these differences seem to be present already at birth. Accordingly, cardiovascular and 
musculoskeletal disorders were enriched in the diseases analyses.
The enrichment analysis revealed a possible role of our gene set to the brain as CpG sites and genes are modulated 
during brain development on top of being differently methylated between sexes39. Furthermore, these genes 
have been associated to psychiatry diseases as demonstrated by the enrichment of the 2,332 DMSs between 
females and males among the 4,641 differentially methylated CpG sites in brain tissue between patients with 
schizophrenia and controls40. Among the common genes, SHANK genes participate in synaptic formation, including 
in SHANK2 and SHANK3, in which mutations were described in a wide spectrum of neurodevelopmental 
and neuropsychiatric diseases47.
When analyzing the near and distant motifs for sex hormones, we suggested that: (1) the differential meth-
ylation found in CpG sites could interfere with the binding in motifs close to TSS of transcriptional factors clas-
sically related to females and males and; (2) other factors that are not exclusively associated with the regulation 
performed by sexual hormones are contributing to differentially expressed and methylated genes between females 
and males. Also, most of the DMS (66%) showed higher DNA methylation in females compared to males. It has 
been reported that females have higher methylation levels than males, although most studies used the X and Y 
chromosomes in their analyses, where a substantial portion of the DMSs are located34. Importantly some of these 
studies were performed in tissues other than cord blood, such as brain or pancreas, and with older subjects, that 
present changes in methylation because of the aging process35,48,49.
X dosage and the presence of Y chromosome exerts a role for the methylation patterns on the autosomes. One 
X was associated to hypomethylation on the autosomes but the presence of Y changes this pattern, suggesting the 
existence of an interaction between X and Y dosages50, meaning that, in addition to the organization effects of 
gonadal hormones, the sex chromosomes contribute to the differential methylation between females and males 
and these differences might contribute the sex bias psychiatric vulnerabilities, agreeing with a previous published 
discussion43.
The importance of considering the sex differences relies on the different response from females and males to 
stress to maintain homeostasis, which may have different consequences for the long-term responses to pertur-
bations from the environment33. Prenatal stress can induce long-term neurodevelopmental diseases, particular 
those related to the hypothalamic-pituitary-adrenal (HPA) response to stress51. This exposure to maternal stress 
may alter the stress-vulnerability of the embryo leading to an increased risk of psychopathology36. The cohort 
from CHAMACOS was subjected to toxic stress (e.g. exposure to pesticides)34 whilst our study excluded factors 
already associated with psychiatric vulnerabilities (not born at term and not adequate size/weight for gestational 
age); and corrected for stress factors covariables that potentially interfere with DNA methylation. Psychiatric dis-
orders were associated to genes from both studies. Nevertheless, comparing both data, we found 890 overlapping 
CpG sites, with our methylation differences (delta-beta) being smaller than theirs were, suggesting that exposition 
to stress might increase these differences. Comparing both datasets to the co-expressed gene modules during 
neocortical development revealed that some modules were similarly enriched. In addition, genes from these 
modules (M8: SOX1, CDKN2C, TRIP10, SALL1, EFNA4, PARD3B, CDH23, PRDM16, NEK9, C1orf61, HSPB1, 
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Figure 2. Enrichment analysis for the modules from Parikshak et al.41, that identified genes co-expressed 
during cortical development. Graphs show the distribution of genes related to the studies in enriched modules 
(p < 0.05). Scatter smooth of module eigengene values was defined by Parikshak et al.41 at different stages of 
neocortical development. Different periods of lifetime are scaled from light to dark blue colors: early foetal, 
early-mid foetal, late midfoetal, late foetal, neonatal/early infancy and late infancy. The red line indicates time of 
birth. Sets of genes enriched for the modules are displayed below of each graph.
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CCDC8, FLNB and TEAD3; M13: RTKN, SYN2, SYNGR1, NRXN3, PRSS16, CPLX1, ZNF365 and SLC17A7; M17: 
CYP1A1, GRIN1, GRIN2D, PRPH, CSMD1, BTBD9, UPP2, and USP12) were found among genes enriched for 
the overrepresented psychiatric diseases. For instance, SYN2, more methylated in females (cg10245988, island), 
encodes a neuron-specific phosphoprotein that selectively binds to small synaptic vesicles in the presynaptic 
nerve terminal. Polymorphisms in this gene were associated with abnormal presynaptic function and increased 
risk for related neuronal disorders, including autism, bipolar disorder and schizophrenia52–54. SNPs in UPP2 
were associated with a sex-bias factor in children diagnosed with autism spectrum disorder55. Nonetheless, the 
enrichment analysis of specific datasets reported different groups of genes regarding their expression levels during 
neurodevelopment, suggesting specific contributions.
We are aware that this study has limitations. First, we controlled for a limited number of stress factors and 
cannot guarantee that the methylation analyses were not influenced by unexplored stress exposition factors. 
Second, we could not measure contamination of maternal cells and thus, did not correct for it. Third, compari-
sons between data from cord blood and brain were not performed with samples collect from the same individuals. 
Fourth, we used only exposure to pesticides and environmental chemicals as a model toxic stress. Finally, we 
found only one study with publicly available data that used the H450K to evaluate DNA methylation in the brain 
of patients with schizophrenia representing psychiatric diseases found enriched in our analyses.
This study corroborated previous findings from the literature that showed that methylation differences 
between females and males in the cord blood methylation are associated with brain developing tissues. We 
describe there that genes related to this differential methylation are enriched for genes previously associated with 
psychiatric diseases, even after correcting the methylation analysis for stress exposition covariables, in additional 
to the technical effects. These differences are not solely explained by gonadal hormone effects, but also by sex 
chromosomes effects on the autosomes. Moreover, they present specific pattern of gene co-expression organized 
in modules of neocortical development, which implies temporal specific effects.
Material and Methods
Sample collection. Samples came from the Western region of Sao Paulo city, where 6,200 women were 
enrolled between 26th and 34th week gestation between 2012–2014 (Regiao Oeste Cohort, ROC). For this study, 
a questionnaire was administered to mothers to evaluate levels of stress and toxic exposures during gestation 
(smoke, use of drugs). These children are being followed up to gather additional information related to neurode-
velopmental diseases and behavioral phenotypes as a continuum of this study; this will not be explored in here 
due to the relatively small time-lapsed. We collected blood from the umbilical cord of 96 women that delivered 
at the University Hospital of Sao Paulo. All women gave written informed consent to participate in the study. The 
study itself, as well as the use of samples, were conducted with ethical approval granted by the Hospital’s Internal 
review board – CEPHU under protocol number 1076/10, with all experiments performed in compliance with the 
Helsinki Declaration.
Sample preparation and quality control. DNA was isolated from umbilical cord blood samples using 
QIAamp DNA Blood Midi Kit (Qiagen). NanoDrop (Thermo Fisher Scientific) and Qubit (Thermo Fisher 
Scientific) was used to assess DNA purity and quantity. DNA quality was checked by electrophoresis in 0.8% 
agarose gels followed by bisulfite conversion whereby 1 ug DNA was treated using the EZ DNA Mehylation kit 
(Zymo Research Corp), following manufacture recommendations.
High quality bisulfite-converted DNA from 96 samples were hybridized in the Human Methylation 450 
BeadChip microarrays (HM450K, Illumina), following the Illumina Infinium HD methylation protocol. Both 
experiments were processed by Deoxi Biotecnologia (www.deoxi.com) according to manufacturer’s instructions. 
Raw data were extracted by the iScan SQ scanner (Illumina) using GenomeStudio software (v.2011.1), with the 
methylation module v.1.9.0 (Illumina), into IDAT files, which were used for further analyses. The HM450K plat-
form interrogates DNA methylation levels of 485,577 loci distributed across the genome at single-nucleotide 
resolution. Probes were annotated according regarding their nearest genes using FDb.InfiniumMethylation.hg19 
package with an additional annotation for those probes that were located at more than one gene, Hg19 coordi-
nates from UCSC were selected. This resulted in 20,461 unique entrezID genes. The methylation levels for each 
CpG probe were provided in beta-values (0 indicating unmethylated CpGs, and 1, fully methylated CpGs). All 
analyses were performed in R environment using Bioconductor packages (http://www.bioconductor.org). All 
samples had high quality data passing QC using standard parameters.
Genome-wide methylation analysis. The RnBeads package56 was applied to the dataset. Unreliable 
measurements were identified using Greedycut (p > 0.05) that removed 1,478 probes. Probes located in SNPs 
(n = 4,776) as well those located in specific contexts (n = 5,926 – non-CpG sites as well as additional SNPs) were 
also excluded. Samples were retained only if > 99% of sites assayed had detection p > 0.05. The background was 
corrected using noob method, which is based on a normal-exponential convolution using out-of-band probes57. 
Signal intensities values from probes type I and II were normalized using SWAN method that adjusts the inten-
sities based on a quantile approach58. Probes located in the sexual chromosomes were filtered out remaining 
464,964 probes for analyses.
To quantify methylation differences resultant from cellular composition of the blood, a purified dataset contain-
ing six blood cell types was used as ref. 59 to estimate the blood cell type contribution for each cord blood sample. 
Based on the estimated percentages of each cell type, a projection of the methylation levels for each cord blood sam-
ple was used in the limma based analysis of differential DNA methylation, as implemented by RnBeads56. Variables 
from the questionnaire were tested for association with the main group comparison (female versus male) indicating 
that only psychiatric disease in the father family was acting as co-variables. Moreover, adjustment for technical 
effects (e.g. batch effects) and cell type composition were performed before the differential methylation analyses.
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To identify differentially methylated CpG sites (DMSs), the M-values (loggit of B-values) were used employ-
ing an empirical Bayesian framework linear model from limma60. CpG sites with FDR adjusted p-value (adjP) < 
0.05 were selected as differentially methylated. RnBeads also identified differentially methylated regions (DMRs) 
in pre-defined CpG islands, promoters, genes and genome-wide tiling regions, that exhibit DNA methylation 
changes between females and males (FDR adjP < 0.05).
In silico functionally exploration of data. Functional and disease enrichment analysis were performed 
in WebGestalt61 using the whole genome as background. Significant values were considered to be those fea-
tures comprised by at least 10 genes and adjusted p-value (adjP) < 0.01 adjusted by the multiple test as given by 
Benjamini–Hochberg procedure.
CpGs were compared to differentially methylated CpG sites found by three studies with publicly available 
data34,40,62 using all probes from 450 K BeadChip as background. In addition, genes associated to DMSs were com-
pared to 17 modules comprised of co-expressed genes during human cortical development41. For both cases, we 
applied the Modular Single-set Enrichment Test (MSET)62, which assess enrichment for a gene or CpG site (here 
named as feature) list of interest within a set of features using a randomization testing. First, the probability of our 
list of features being significantly represented in each module were compared to 10,000 simulated sets of features 
generated randomly from the 450 K Beadchip array (for DMS) or RefSeq (for genes) as background. Then, a 
p-value was calculated based on the number of simulated randomized sets that contains equal or higher number 
of features belonging to our list of features in the list generated by each of the three studies. We considered as 
significant, those comparisons with a p-value < 0.05. For the comparison with modules of genes co-expressed 
during neocortex development, the module eigengene values from the original study41 were plotted in a scatter 
smooth plot for the significant modules.
Data access. The HumanMethylation450 BeadChip data set from this study is available in NCBI Gene 
Expression Omnibus (GEO) under accession number GSE85042.
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